Reaction Injection Molding (RIM) was invented in Germany in the 1970s, and made its way to America about 10 years later. Originally used for producing automotive components, RIM is a low-pressure, low-temperature process that uses urethane thermoset resins.
The Food and Drug Administration has approved a radioactive imaging chemical from General Electric to help screen for Alzheimer's disease. The drug, Vizamyl, is an injection of radioactive material designed to highlight abnormal brain plaque in medical imaging scans.
Medical device maker Stryker will pay the U.S. government $13.3 million to settle allegations it made illegal payments to government employees in five countries. The SEC said Stryker subsidiaries made $2.2 million in illegal payments to government employees in Mexico, Poland, Romania, Argentina, and Greece between August 2003 and February 2008.
Boston Scientific Corp. says it plans to shed as many as 1,500 jobs worldwide, or about 6 percent of its work force, in an effort to cut costs. The company also says its CFO is leaving. Boston Scientific is promoting its corporate controller to replace him.
Could 3-D printing, also called additive manufacturing, revolutionize the production industry to the same extent as Ford's assembly line? When Michelangelo was asked how he sculpted the famous David statue, he's reported to have simply replied, "I just chipped away everything that didn't look like David."
The Justice Department says Boston Scientific Corp. and its Guidant subsidiaries will pay $30 million to settle allegations that Guidant knowingly sold defective heart devices that health care facilities implanted in Medicare patients from 2002 to 2005.
Achim Steiner, the executive director of the U.N. Environment Program, says the Minamata Convention on Mercury, which was formally adopted as international law last week, sends "a very clear signal" that the use of mercury in industrial processes, cosmetics and medical equipment is essentially over.
An Israeli nonprofit group has awarded a $1 million prize to a U.S.-based research team that is developing technology that allows paralyzed people to move things with their thoughts.Israel Brain Technologies presented the award on Tuesday to BrainGate.
Short term improvements in jobs or sales are like a sick person getting some medicine from the doctor and feeling better the next day. A very thorough examination of all of the vital signs might show that the patient actually has a debilitating disease that will eventually render the patient bedridden over time.
Whether launching a new product, improving a product, entering a new market, meeting customer demands, or responding to market or technology changes, manufacturers need the ability to swiftly adapt their products to satisfy new requirements or conditions.
The work is not nearly enough to prove a link, but it adds to "the biological plausibility" that BPA might affect fertility and other aspects of health, said Dr. Linda Giudice, a California biochemist who is president of the American Society for Reproductive Medicine.
The first-of-a-kind device was developed by California-based startup, Nanostim, with funding from St. Jude. The Minnesota-based device giant also said it would acquire of the smaller company for $123 million, under a previously negotiated option agreement between the two companies.
The artificial "man" is the subject of a Smithsonian Channel documentary that airs Sunday, Oct. 20. Called "The Incredible Bionic Man," it chronicles engineers' attempt to assemble a functioning body using artificial parts that range from a working kidney and circulation system to cochlear and retina implants.
The Human Brain Project, co-funded by the European Union, plans to use supercomputers to model the brain and then simulate drugs and treatments for diseases that cost hundreds of billions of euros annually in Europe alone.
Unfortunately, because innovative ideas are ones no one else has, we can’t know for certain how successful those ideas will be. Likewise, because they are new and different, the development expense of innovative ideas is often high. The bottom line is that the risk of new and different ideas is great.
What sounds like a dream of the future has already been the subject of research for a few years: simply printing out tissue and organs. Now scientists have further refined the technology and are able to produce various tissue types.
Making best use of resources is good, but figuring out how isn’t necessarily a Lean Event. Five-S is a good practice, but declaring an emergency just to clean up appearances for a visitor completely misses the intent. Quotas of activity do not necessarily beget improved performance.
The Missouri Society of Anesthesiologists statement followed an Associated Press report last week citing possible European export controls if propofol is used in a U.S. execution. Missouri is the only U.S. state where prison officials plan to use the powerful anesthetic for a lethal injection, citing a shortage in the drugs usually used for executions.
On the brink of a government shutdown, the Senate voted 54-46 on Monday to strip a one-year delay in President Barack Obama's health care law from the bill that would keep the government operating. The Senate also stripped a provision that would have eliminated the tax on medical devices.
More than 235 million people worldwide suffer from asthma, according to the World Health Organization. So, when Italian pharmaceutical company, ChiesiFarmaceutici, developed a new medicine in the form of a powder, they turned to product development firm Cambridge Consultants for a revolutionary inhaler design.
Medical device maker Integra LifeSciences said Thursday that it has resolved a mold problem at a collagen manufacturing facility in Plainsboro, N.J.In December 2011, the Food and Drug Administration sent Integra a warning letter about mold in the facility, saying it could affect the company's products.
This year's study, based on respondents in the United States, China, India, Germany and Brazil, highlighted some of the characteristics of a more complex global marketplace. It found that while fundamentals such as quality, safety and innovation remain the most important factors driving behavior for manufacturers and consumers, a number of priorities such as transparency, health impact and outsourcing/country of origin are on the rise.
Tommy and Barbara Sowards are suing for damages after they say the doctor implanted an unneeded pacemaker when Tommy Sowards went to MountainView Regional Medical Center in Las Cruces in January 2007. They're suing cardiologist Dr. Demosthenes Klonis, the hospital and pacemaker manufacturer Biotronik, Inc.
Stryker is buying Mako Surgical for about $1.41 billion, giving the medical device maker access to all of its robotic assisted surgery technology. Stryker will pay $30 per Mako share, an 86 percent premium to its $16.17 closing price Tuesday. The companies put the deal's value at about $1.65 billion.
IDSA is my favorite conference to attend because it’s not just people talking about good design; it’s filled with conversations about how design can transform lives. It’s a very powerful message, especially in today’s society of design-centric businesses.